Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Choosing the right gas credit card can save you money. Explore different options tailored to your spending habits.
22,528 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
A trio of S&P 500 dividend stocks that pay monthly dividends are outperforming the broader index, delivering reliable...
Realty Income has built a legendary monthly dividend streak. This analysis evaluates whether the stock still makes se...
Berkshire Hathaway's Bank of America stake remains a defining part of its portfolio, even as the company reshapes its...
Plug Power has dropped sharply after a run higher, amid rate fears and subsidy uncertainty. This article explains why...
In 2026, choosing between State Street's XLF and Fidelity's FNCL comes down to breadth versus focus. This guide break...
Nvidia and Broadcom lead the AI chip market, but which one deserves a place in a modern portfolio? This guide breaks ...
As markets wobble in early 2026, investors are increasingly pursuing a hybrid approach that blends bonds and dividend...
Nebius stock fell today after the company announced debt issuance to fund its infrastructure push and key AI partners...
With the rate cuts table still unsettled, contrarian investors are targeting under-$30 names with strong balance shee...
M/I Homes is rolling out Prophetic's AI-native land platform across its markets to speed site evaluation. The move si...
Suze Orman questions the blanket push to claim Social Security at 62. This article explains who would benefit from ea...